The Europe Protein Labeling Market would witness market growth of 6.8% CAGR during the forecast period (2022-2028).
Protein labeling is a technique in which molecular labels are covalently added to a targeted protein molecule to make detection and purification of the labeled protein and its binding partners easier. The molecular labels utilized in this technique covalently connect to the intended protein target, such as biotin, enzymes, fluorophores, and radioactive isotopes. It consists of several labels based on the various applications for a certain application. The growth of the protein labeling market is supported by the developments in the medical healthcare sector and rising R&D spending.
Proteins are made up of polypeptide chains, and the precise folding, size, and quantity of reactive functional groups present all through the polypeptide chain dictate their biological activity. A wide range of features and their overall biological function can be explored because of the ability to give site-specific protein alterations. Putting fluorophores, biotin, and other small molecules into proteins allows protein interactions, protein folding, and the complete structure of proteins as well as the biological function.
As people show willingness to live longer and healthier lives, the demand for breakthrough medical technology solutions like protein labeling continues to rise. This opens up chances for the medical technology industry, which is nearly completely made up of small and medium-sized businesses in Germany. The researchers are actively working on discovering new and advanced technologies in the protein labeling. The local market's upbeat outlook, along with strong exports of Medtech Made in Germany, resulted in an increase in domestic industry turnover. With a decent share of overall medical technology production, Germany is the world's third-biggest manufacturing nation.
Many manufacturers in the medical technology sector each with more than certain number of workers invest a fixed share of the revenue in R&D in advanced technologies like protein labeling. This, although, is only evidence of Germany's high degree of innovative strength. Therefore, due to increased demand for advanced medical technology in the regional medical sector, the protein labeling market is likely to propel in the forecast period.
The Germany market dominated the Europe Protein Labeling Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $193.9 million by 2028. The UK market is estimated to grow at a CAGR of 5.9% during (2022 - 2028). Additionally, The France market would witness a CAGR of 7.6% during (2022 - 2028).
Based on Method, the market is segmented into In-vitro (Enzymatic, Dye-based, Co-translational, Site-specific, Nanoparticle, and Others) and In-vivo (Photoreactive, Radioactive, and Others). Based on Product, the market is segmented into Reagents, Kits, and Services. Based on Application, the market is segmented into Immunological Techniques, Cell-based Assays, Fluorescence Microscopy, Protein Microarray, and Mass Spectrometry. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Protein Labeling Market will Hit $3.2 Billion by 2028, at a CAGR of 7.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Merck Group, PerkinElmer, Inc., General Electric (GE) Co., F. Hoffmann-La Roche Ltd., Kaneka Corporation, New England BioLabs Inc., Promega Corporation, LI-COR, Inc., and SeraCare Life Sciences.
By Method
By Product
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
